| 摘要 |
The present invention relates to rapidly disintegrating oral drug prepara tions for the application of active agent combinations for diabetes therapy, wherein the drug preparations contain at least two active agents suitable f or treating type-2 diabetes, and where the antidiabetic active agents are se lected from the group comprising sulfonylureas, glitazones, glinides, biguan ides, and resorption inhibitors. The present invention is further aimed at t he use of the active agent combination in accordance with the invention to p roduce an oral drug preparation for the treatment of diabetes, at a method f or the therapeutic treatment of diabetes, and at a method for the production of a wafer-like drug preparation.
|
